Why 4/5: Improves access and affordability of life-saving opioid overdose reversal medication.
This bill would reduce out-of-pocket costs for individuals needing opioid overdose reversal medications by requiring health insurers to cover at least one such drug on their lowest cost-sharing tier. It also ensures these life-saving drugs are more readily available by exempting them from prior authorization and step therapy requirements.
Update
Commerce and Labor Substitute agreed to
Substitute adopted
Engrossed by Senate - committee substitute
Passed a chamber
Passed Senate with substitute Block Vote (39-Y 0-N 0-A)
Update
Reconsideration of Senate passage agreed to by Senate (40-Y 0-N 0-A)
Passed a chamber
Passed Senate with substitute Block Vote (40-Y 0-N 0-A)
Substitute adopted
Senate substitute agreed to by House (96-Y 0-N 0-A)
Enrolled
Enrolled
Passed a chamber
Bill text as passed House and Senate (HB795ER)
Passed a chamber
Signed by President
This bill has passed its votes and is headed to the Governor's desk. You still have a say — the Governor's office reads messages before deciding whether to sign.
New to all this? See how a bill becomes law →
Summarized from the official bill text (“Health insurance; requirements for certain opioid antagonists.”) · Read the actual bill →
Passed a chamber
Signed by Speaker
Enrolled
Enrolled Bill communicated to Governor on March 31, 2026
Sent to the Governor
Governor's Action Deadline 11:59 p.m., April 13, 2026
Update
Fiscal Impact Statement from Department of Planning and Budget (HB795)
Signed into law
Approved by Governor-Chapter 423 (effective 7/1/2026)
Update
Acts of Assembly Chapter text (CHAP0423)